Strober , B., Asahina, A., Mrowietz, U., Lebwohl, M., Foley, P., Langley, R., Barker, J., Cioffi, C., Cross, N., Wang, M. . and Paul, C. (2021) “Bimekizumab response maintenance through two years of treatment in patients with moderate to severe plaque psoriasis who responded after 16 weeks: Interim results from the BE BRIGHT open-label extension trial”, SKIN The Journal of Cutaneous Medicine, 5(6), p. s52. doi: 10.25251/skin.5.supp.52.